Latest News and Press Releases
Want to stay updated on the latest news?
-
New York City, March 29, 2026 (GLOBE NEWSWIRE) -- The newly formed firm and group are announcing their intention to raise initial bridge financing through offerings under the U.S. SEC’s Regulation D...
-
NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) between...
-
NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Driven Brands Holdings Inc. (NASDAQ: DRVN) between May 9,...
-
NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June...
-
Alkane Executes $110 Million Revolving Credit Facility
-
Washington, D.C., March 29, 2026 (GLOBE NEWSWIRE) -- The numbers behind the artificial intelligence buildout are staggering. Billions of dollars committed to data centers. Advanced chip acquisitions...
-
Medical AI awarded inaugural Global Digital Health Award at the ACC Annual Scientific Session
-
Bitcoin Everlight opens Phase 3 presale as stablecoin adoption draws broader retail attention to digital asset participation SAN FRANCISCO, March 29, 2026 (GLOBE NEWSWIRE) -- Bitcoin Everlight,...
-
NEW YORK, March 29, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ODDITY Tech Ltd....
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.